We call vaccines “biologics” because vaccinologists have traditionally grown their antigens on biological substrates — usually animal tissue. Competing companies culture COVID vaccines on a variety of animal strata. The Merck and IAVA COVID vaccines are manufactured in vero monkey cells, and thus contain cellular debris and DNA fragments from vero monkeys in the final product. The Sanofi, GSK, and Novavax COVID jabs are manufactured in insect cells and thus contain insect cellular debris and DNA fragments in the final products.

Public health advocates criticize the use of animal tissues in vaccines due to risks that they carry endogenous viruses, microbes, parasites and lack safety testing. (Plague of Corruption, Mikovits 2020). …

Researchers and regulatory agencies have worried for more than 50 years about the potential for injected DNA to cause cancer.  …

Regulators have in the past predicted that the odds of that happening were less than 1 in a trillion. However, in early gene therapy trials this event did indeed occur in 4 of 9 boys, 1 of whom died from the leukemia the insertions caused.

…

FDA as an arm of Big Pharma

…

Between 2000 and 2010, pharmaceutical companies paid the FDA $3.4 billion to gain rapid drug approvals. Today, Pharma companies underwrite three-quarters of FDA’s budget for scientific reviews (ProPublica) and fund nearly 50% of the FDA’s total annual budget through PDUFA fees. In exchange, the agency increasingly fast-tracks expensive drugs and vaccines with significant side effects and unproven health benefits.

Corrupt vaccine approval panels

But as corrupt as FDA is, the internal panels — VRBAC — that approve new vaccines make the rest of the agency look like a Sunday church picnic.

When Dr. Fauci, Paul Offit, Peter Hotez and Bill Gates tell you that you needn’t worry because FDA is the “gold standard” for vaccine safety and that the ultimate licensing decision will be made by an “independent panel of experts,” they are talking about VRBPAC. But VRBPAC is far from “independent.” It is not even comprised exclusively of public officials. Instead, it is populated by outside “experts” who are almost all pharmaceutical industry insiders.

In 2003, following a 3-year investigation, the United States Congress’s House Oversight Committee found VRBAC was completely dominated by the vaccine industry.

“Examples of Conflicts of Interest:

1. “For instance, 3 out of 5 FDA advisory committee (VRBPAC) members who voted to approve the rotavirus vaccine in December 1997 had financial ties to pharmaceutical companies that were developing different versions of the vaccine.
2. “One out of five voting members’ employer had a $9,586,000 contract for a rotavirus vaccine.
3. “One out of five voting members was the principal investigator for a Merck grant to develop a rotavirus vaccine.
4. “One out of five voting members received approximately $1 million from vaccine manufacturers toward vaccine development.”

Congressional investigators concluded that, “Altogether, four out of the five committee members had conflicts of interest that required waivers, and their recommendation for approval of the vaccine was unanimous.”

Here’s what happened at the 2012 FDA meeting on fetal cells

HHS acknowledges that the FDA and Centers for Disease Control committees that contract and review new vaccines have historically not used “evidence-based medicine.” To illustrate what this means, one only need read (below) the astonishing transcript of the 2012 panel that first approved the use of adult cancer tumor cells in vaccines.

This transcript shows what the public is never supposed to see: the behind-the-scenes sausage-making of federal vaccine approvals. Here, you will read for yourself how the “independent,” “gold standard” panelists entrusted with protecting your children made monumentally consequential decisions, not on evidence-based science, but by rolling the dice and taking what they knew was a horrendously risky bet on public health

In any other realm, this transcript would be proof of negligent homicide. … We are all lab rats in their high-risk population-wide experiment. At FDA’s vaccine division, that sort of reckless decision-making is routine.

In 2012, most live virus vaccines were from animal tissue and the idea of putting potentially cancerous tumor cells from adult “donors” in vaccines was still a daring and audacious gamble. That September, the FDA VRBPAC committee met to discuss this risky innovation. The transcript of that meeting — showing captive FDA officials considering a proposal by the pharma cabal to allow the use of human cancer cells (HeLa) to replace animal tissue in the manufacture of vaccines — is proof of reckless criminal conduct.

The HeLa cells are well known to cause cancer in animals, but Big Pharma wanted to lower production costs of vaccines and this method is cheaper and faster than using animal tissue for the cultivated media. …

Unbelievably, FDA voted to allow pharmaceutical companies to produce vaccines using human cells without reviewing a single scientific study to determine if the outcome would be safe.

Before, I quoted some of the criminally reckless statements from the meeting directly. A more detailed account appears in this article.

This was a full meeting of FDA’s VRBPAC in 2012 to decide on the use of human tumor cell lines for the production of vaccines. I list these speakers and their titles at that time:

• Dr. Philip Krause, Acting Deputy Director of OVRR (Office of Vaccine Research and Review) and FDA’s CBER (Center for Biologics Evaluation and Research). Also, Principal Investigator for Vaccine Safety: Virus Detection and Latency.
• Dr. Doug Lowy, Director of the National Cancer Institute of the NIH.
• Dr. Robert Daum, Chair of the VRBPAC.
• Donald W. Jehn M.S., Designated Federal Officer for VRBPAC.
• Keith Peden, PhD, Chief of LDNAV, DVP/OVRR/CBER.
• Dr. Marion Gruber, Director of the FDA’s Office of Vaccines.
• Dr. Nathanial Brady, a self-described clinician.
• Dr. Pamela McInnes, a vaccine development expert and the Director of the Division of Extramural Research at the NIH’s National Institute of Dental and Craniofacial Research, and previously a Deputy Director under Anthony Fauci at the National Institute of Allergy and Infectious Diseases.

Pharma knew that their tumorigenic vaccines might cause tumors in recipients.

…

FDA officials knew that tumors might occur decades after vaccination.

…

FDA openly acknowledged that its primary objective was not to assure public safety but to help vaccine manufacturers.

…

FDA officials knew that they could not prove vaccine safety using test animals to assess oncogenicity.

…

FDA officials deliberately terminated animal safety tests too early in order to conceal consequences.

…

FDA decided to keep the tumor cell lines secret, because doctors and the public may be alarmed and say “Oh, my God!” if they knew the truth.

…

FDA decided to use deceptive language to convince doctors and the public that the vaccines were safe even when they, themselves, were unconvinced of safety.

…

FDA decided to hide information about their use of tumor cells and omit it from package inserts. 

…

Health authorities were skeptical about safety of the tumor lines, but they decided to subject the public to the risk, so that they could perform a global population-wide live human experiment.

…

FDA officials opted to toss the dice, perform the population-wide human experiment, and learn about the risks as time goes by.

…

The committee formally approves the method of making vaccines from human cancer tumors.

..

Prior to voting to go forward, the committee made the following conclusions:

• Making vaccines with cells that are directly derived from human cancer tumors is faster and cheaper than breeding animals for the culture media.
• Millions of potentially cancer-causing vaccines will be produced.
• The vaccines may possibly cause genetic mutations.
• Millions of dollars will be made by vaccine promoters.
• The health of millions of consumers may be jeopardized.
• Information about how vaccines are made will be hidden from doctors and

Finally, it’s worth considering that cancer treatment drugs like Keytruda are among pharmaceutical companies’ largest profit makers. Precipitating a cancer epidemic in human populations only benefits vaccine makers’ bottom line.

Remember, these are the same companies and the same FDA regulators that brought us the opioid epidemic.

from:    https://childrenshealthdefense.org/defender/fda-cancer-cells-in-vaccines/?utm_source=salsa&eType=EmailBlastContent&eId=8fc80363-cace-4de1-bcd2-9e309b779ac5